EN
抗体药类似物
Research Grade Suvizumab
All
TD-VK617016_1.jpg
TD-VK617016_2.jpg
TD-VK617016_3.jpg
  • CatalogTD-VK617016
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsKD-247,CAS:914257-21-9
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Suvizumab


Catalog No. TD-VK617016
Species reactivity Human immunodeficiency virus 1 (HIV-1)
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1, kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target env/Env polyprotein
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P03377
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names KD-247,CAS:914257-21-9
Background Suvizumab (KD-247) is an neutralizing antibody anti-HIV-1. Suvizumab effectively neutralizes HIV-1MN, HIV-1SF2 and HIV-189.6 with IC50 values of 0.1 µg/mL, 1.0 µg/mL and 0.2 µg/mL, respectively. Suvizumab reduces the viral load of HIV. Suvizumab has good tolerance and can be used to prevent HIV infection.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-VK617016_1.jpg
SEC-HPLC
 
SEC-HPLC detection for Research Grade Suvizumab.
TD-VK617016_2.jpg
标题
 
Detects env/Env polyprotein in indirect ELISAs.
TD-VK617016_3.jpg
标题
 
SDS-PAGE for Research Grade Suvizumab.